Cancer treatment controls macular edema related to diabetes and to cataract surgery
SAN FRANCISCO, CA---This month's Ophthalmology , the journal of the American Academy of Ophthalmology, reports on use of bevacizumab (Avastin), to benefit diabetic patients with macular
edema as well as people who develop cystoid macular
edema after cataract surgery. Bevacizumab is also used to t...
Medical Study Establishes First-Ever Long-Term Benefits for Macular Degeneration Sufferers Using Macular Health Vitamin Supplement
BIRMINGHAM, Ala., June 23 /PRNewswire/ -- According to the World Health Organization (WHO), age-related macular
degeneration (AMD) ranks third as a cause of visual impairment. It is the primary cause of visual impairment in industrial countries with a blindness prevalence of 8.7 percent. A new ...
New Medical Study Establishes First-Ever Long-Term Benefits for Macular Degeneration Sufferers Using Macular Health Vitamin Supplement
Eye disease product has the potential to preserve vision for millions
BIRMINGHAM, Ala., April 28 /PRNewswire/ -- As many as 17.8 million people will suffer from age-related macular
degeneration (AMD) by 2050 and 1.57 million will be blind from the disease, according to the U.S. Centers for Di...
Nearly 18 Million Will Have Macular Degeneration by 2050
But newer treatments could reduce related blindness by almost 35%, study suggests,,,,
TUESDAY, April 14 (HealthDay News) -- Although the rate of age-related macular
degeneration is on the increase, newer treatments could help reduce the most serious effects of the disease by about 35 p...
FDA Advisory Panel Recommends Approval of VisionCare's Implantable Telescope for End-Stage Macular Degeneration
SARATOGA, Calif., March 30 /PRNewswire/ -- VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices for individuals with age-related macular
degeneration (AMD), today announced the FDA Ophthalmic Devices Advisory Panel unanimously recommended that the FDA approve...
VisiVite.com Files for Patent on Unique Macular Degeneration Supplement
Removal of Vitamin E from High Dose Eye Vitamins Provides Safety for Certain Patients.
Huntington, NY (PRWEB) November 18, 2008 -- VisiVite.com, an industry leader in eye health supplements, announced this week the filing for a United States patent application for an ey...
Macular in Medical Technology
Potentia Pharmaceuticals' POT-4 Drug Candidate for Age-Related Macular Degeneration Successfully Completes Phase I Clinical Trial - Prepares for Phase II
POT-4 well tolerated by all subjects and sustained levels of drug reported after one treatment
LOUISVILLE, Ky., May 4 /PRNewswire/ -- Potentia Pharmaceuticals, a privately held biotechnology company developing medicines for the treatment of age-related macular
degeneration (AMD), announced to...
Optherion Announces Issuance of Canadian Patents Covering Age-Related Macular Degeneration Diagnostics and Treatments
Issuance of Canadian Patents 2,363,503 and 2,407,715 Strengthens Intellectual Property Position of Optherion's Novel Diagnostics for Age-Related Macular
NEW HAVEN, Conn., April 30 /PRNewswire/ -- Optherion, Inc., a company developing novel molecular diagnostics and treatments for...
Tufts Medical Center Researchers Create a New Predictive Model for Age-related Macular Degeneration (AMD)
BOSTON, April 23 /PRNewswire-USNewswire/ -- Researchers at Tufts Medical Center have created a formula for predicting how likely it is that individuals with certain genetic profiles and lifestyle behaviors will develop advanced Age-related Macular
Degeneration (AMD), a potentially blinding conditi...
ThromboGenics Completes Patient Enrolment for Phase II Trial of Microplasmin for the Treatment of Diabetic Macular Edema (MIVI II DME)
LEUVEN, Belgium, March 6 /PRNewswire-FirstCall/ -- ThromboGenics NV
(Euronext Brussels: THR), a biotechnology company focused on innovative
treatments for eye disease, vascular disease and cancer, today announces that
it has completed patient enrolment for a Phase II trial of microplasmin
TOZAL(R) Nutritional Supplement Improves Vision in Common Form of Macular Degeneration
- Multicenter study finds unique combination of micronutrients superior to
current 'AREDS' standard of care; Results supported by new omega-3 study -
HOUSTON, Sept. 10 /PRNewswire/ -- A landmark study at five
university-based research centers found that TOZAL(R), a patented
combination of anti...
Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
Clinical Program Leverages Quark's RNAi Technology
FREMONT, Calif., July 30 /PRNewswire/ -- Quark Pharmaceuticals, Inc., a
development-stage pharmaceutical company discovering and developing novel
RNA interference (RNAi)-based therapeutics, today announced that its
partner, Pfizer Inc, initi...
Macular in Medical Products
MacularProtect Complete®-S Powerful Protection for Macular & Full Body Health
Description: MacularProtectComplete®-S is a scientifically advanced nutritional formulation that provides powerful protection for macular
and full body health. MacularProtect Complete-S, based on the AREDS clinical trial and other advanced research, delivers a diverse array of antioxidants, such as 10 mg of...
MacularProtect® Protection for Macular Health
Description: MacularProtect delivers levels of nutrients found to help preserve vision and macular
health in the AREDS clinical trial, supported by The National Eye Institute. MacularProtect also delivers 10 mg of lutein, an antioxidant found to play an important role in eye health in other advanced research....
MacularProtect Complete® Powerful Protection for Macular & Full Body Health
Description: MacularProtect Complete® is a scientifically advanced nutritional formulation that provides powerful protection for macular
and full body health. MacularProtect Complete is based on the AREDS clinical trial and other advanced research. It features a comprehensive multinutrient component that pr...
Description:... AMD Now is a forum presenting interactive education on Age- related macular
Degeneration (AMD), AMD diagnosis and treatments, VEGF, aseptic technique and supportive care for patients and caregivers....
Description:... MacularProtect Plus® is an advanced scientific formulation that provides powerful protection for macular
health. MacularProtect Plus is based on the AREDS clinical trial, and also incorporates other advanced science supporting the role of lutein in eye he...
Ocuvite® PreserVision® Tablets AREDS formula
Description:...ute (a division of the National Institutes of Health) showed that a unique vitamin and mineral supplement may help slow the progression of age-related macular
degeneration and its associated vision loss among patients most at risk....
Company:Bausch & Lomb, Inc.
Macular in Medical Definition
... - Retinopathy - Retinopathy of prematurity - macular
degeneration - Retinitis pigmentosa - macular
edema - Epiretinal membrane - macular
Ocular muscles , binocular movemen...
PUVA for the treatment of psoriasis
Photodynamic therapy (PDT) for treatment of cancer and macular
Free electron laser
Laser hair removal
Optical diagnostics, for example Optical Coherence Tomography using infrared light of co...
Macular in Medical Dictionary
...e vision, ... Read about visual field testing and vision tests (Amsler grid, Humphrey-Zeiss and Goldman perimetry tests) for glaucoma and macular
degeneration detection. The visual field refers to the total area in which objects can be seen in the ... Your responses help determine if yo...
...ing primary vision care benefits through a broad-based provider network. Find information on eye and vision conditions including glaucoma, macular
degeneration, pink eye, cataracts, and others. Covers symptoms, tests, surgery, and more. News, resources, products and equipment of machine visi...
...ans′lō kā′s̸hən, tranz′-) noun ... Simply put, macular
translocation is an experimental surgical procedure which ... macular
translocation is not a cure for macular
degeneration, but it is showing ... To assess ...
.... ... SCOTOMA . DESCRIPTION: Portion(s) of the retinal field that are non-functional (i.e., blind areas). Scotomas may be central, if caused by macular
or optic nerve ... Scotoma are officially call it a quits! After 15 years thrashing around finally the end came. ... 1994 - SCOTOMA (demo ta...
...matan and heparan ... Hamilton E, Pitt P. Articular manifestations of Scheie's syndrome . ... Quigley HA, Goldberg ME Scheie's Syndrome and macular
corneal dystrophy: an ... Definition of Scheie's syndrome in the Online Dictionary. Meaning of Scheie's syndrome . ... Scheie's syndrome...
...ding opthamologists specializing in treatment of macular
degeneration, retinal detachment, macular
holes, and all retina diseases. Located in Memph... Specialists in all retinal disorders including macular
Macular in Biological News
Blood vessel protein reverses macular degeneration, diabetic retinopathy in mice
SALT LAKE CITY Two major eye diseases and leading causes of blindnessage-related macular
degeneration and diabetic retinopathycan be reversed or even prevented by drugs that activate a protein found in blood vessel cells, researchers at the University of Utah School of Medicine and several other i...
New treatment for age-related macular degeneration within sight
With 8 million people at high risk for advanced age-related macular
degeneration, researchers from Harvard and Japan discovered that the experimental drug, endostatin, may be the cure. A research report published in the December 2007 issue of The FASEB Journal, describes how giving endostatin to m...
Light-sensitive photoswitches could restore sight to those with macular degeneration
A research center newly created by the University of California, Berkeley, and Lawrence Berkeley National Laboratory (LBNL) aims to put light-sensitive switches in the body's cells that can be flipped on and off as easily as a remote control operates a TV.
Optical switches like these could trigge...
New DNA and RNA aptamers offer unique therapeutic advantages
...roved stability and residence time in the bloodstream. Aptamer therapeutics presently in clinical development target diseases and applications such as macular
degeneration, coronary artery bypass graft surgery, and various types of cancer.
Kristina W. Thiel, PhD and Paloma H. Giangrande, PhD, from the Uni...
Natural compound stops retinopathy
...leakage, blocked inflammation and kept unwanted blood vessels from growing. Researchers are now testing the compound's uses for cancer and age-related macular
New supplement may help slow sight loss in elderly
...al supplements for patients with early age-related macular
(AMD) degeneration and found they helped sharpen v...e of high levels of both carotenoids preserved the macular
pigments, slowing down the progression from early AMD to late AMD.
In contrast, the macular
pigments of participants in a placebo group declin...
Macular in Biological Technology
Calvert Research Licenses Novel Technology to Treat Age Related Macular Degeneration from Tulane University
Calvert Research, LLC (a unit of Calvert Holdings, Inc.) today announced the execution of a license agreement with Tulane University granting Calvert Research (through its wholly owned subsidiary, Calvert T1, LLC) certain rights to issued patents and patent applications covering a technology plat...
Robust Annual Growth Through 2012 in the Age-Related Macular Degeneration Market Will Be Driven by Expanding Use of Lucentis in Europe
However, Off-Label Use of Avastin Will Take Market Share Away from Lucentis from 2012 to 2017, According to a New Report from Decision Resources
WALTHAM, Mass., March 10 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcar...
EyeScience Launches Comprehensive Online Resource Devoted to Age-Related Macular Degeneration Education and Prevention
COLUMBUS, Ohio, Feb. 24 /PRNewswire/ -- EyeScience Labs has launched www.EyeScience.com to fill a large consumer need for comprehensive information and education on age-related macular
degeneration (AMD) in a unique watch-and-learn video format. AMD is a progressive, hereditary eye disease that ...
Potentia Pharmaceuticals' Drug Candidate for Age-Related Macular Degeneration Shows Positive Safety Profile in Phase I Clinical Trial
AMD Patients Treated with POT-4 Demonstrate No Adverse Toxic Effects
ATLANTA, Nov. 10 /PRNewswire/ -- Potentia Pharmaceuticals, a privately
held biotechnology company developing medicines for the treatment of
degeneration (AMD), presented Phase I data last week
Notal Vision chooses TrialStat's ClinicalAnalytics 4.0 for age-related macular degeneration (AMD) device trial
ClinicalAnalytics 4.0 Links Images of Study Participant Eyes with Wet AMD to Electronic Case Report Forms (eCRFs)
OTTAWA, Dec. 13 /PRNewswire/ - TrialStat Corporation, the industry's
first clinical data solutions on demand company, today expanded its
international customer base w...
Purification of the Components of Human Macular Carotenoid-Binding Complex,
region of the human retina is responsible for almost all color
vision and most of the high
resolution visual acuity. This part of the retina, known as the macula
lutea, or yellow spot, accumulates
Macular in Biological Definition
Tapetum lucidum (not in humans)
Eye Related Problems
Macular in Biological Dictionary
...anthophyll cycle is a ... xanthophyll cycle, anthocyanins require no enzymes to function and are ... XANTHOPHYLL CAROTENOIDS AND AGE-RELATED macular
DEGENERATION. The high levels of the xanthophylls in the macula may indicate a protective role ... Analysis of the xanthophyll binding LHC pro...
...ry. Schedule an appointment today for treatment of macular
degeneration or vitreous detachment. EYE AND R... Specialists in all retinal disorders including macular
hole and pucker, diabetic retinopathy, and retinal...